Repligen Corporation RGEN
NASDAQ · United States · Health Technology
$177.23-15.00 (-7.80%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $178.09 | -0.48% · below |
| 50-period average | $168.78 | +5.00% · above |
| 200-period average | $143.40 | +23.59% · above |
| Avg. volume (1Y) | 983.19K |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.